海南医学
海南醫學
해남의학
Hainan Medical Journal
2015年
20期
3041-3045
,共5页
肥胖%卵巢功能%不孕症%减重%奥利司他
肥胖%卵巢功能%不孕癥%減重%奧利司他
비반%란소공능%불잉증%감중%오리사타
Obesity%Ovarian function%Infertility%Weight loss%Orlistat
肥胖与育龄期妇女生育能力的关系极为密切,尤其是以腹型肥胖者更加明显,此类人群多表现为月经稀发、雄激素水平增高及排卵障碍.此外,研究表明肥胖人群较正常人群更易发生多囊卵巢综合征、高雄激素血症和代谢功能异常.基础性激素水平紊乱可能是导致不同类型肥胖的关键因素之一,并且在大量研究中已证实降低体重可纠正性激素紊乱状态,降低雄激素水平,建立规律月经周期,恢复排卵,进而提高肥胖女性生育能力.以往针对此情况多采用二甲双胍等药物,通过改善胰岛素抵抗等途径增强卵巢功能,提供生育能力.近年来减肥药物因其具有减脂、改善胰岛素抵抗等作用,被用于此类患者的治疗,本文则对近年来多囊卵巢综合征与育龄期肥胖妇女生育能力及相关药物治疗进行综述.
肥胖與育齡期婦女生育能力的關繫極為密切,尤其是以腹型肥胖者更加明顯,此類人群多錶現為月經稀髮、雄激素水平增高及排卵障礙.此外,研究錶明肥胖人群較正常人群更易髮生多囊卵巢綜閤徵、高雄激素血癥和代謝功能異常.基礎性激素水平紊亂可能是導緻不同類型肥胖的關鍵因素之一,併且在大量研究中已證實降低體重可糾正性激素紊亂狀態,降低雄激素水平,建立規律月經週期,恢複排卵,進而提高肥胖女性生育能力.以往針對此情況多採用二甲雙胍等藥物,通過改善胰島素牴抗等途徑增彊卵巢功能,提供生育能力.近年來減肥藥物因其具有減脂、改善胰島素牴抗等作用,被用于此類患者的治療,本文則對近年來多囊卵巢綜閤徵與育齡期肥胖婦女生育能力及相關藥物治療進行綜述.
비반여육령기부녀생육능력적관계겁위밀절,우기시이복형비반자경가명현,차류인군다표현위월경희발、웅격소수평증고급배란장애.차외,연구표명비반인군교정상인군경역발생다낭란소종합정、고웅격소혈증화대사공능이상.기출성격소수평문란가능시도치불동류형비반적관건인소지일,병차재대량연구중이증실강저체중가규정성격소문란상태,강저웅격소수평,건립규률월경주기,회복배란,진이제고비반녀성생육능력.이왕침대차정황다채용이갑쌍고등약물,통과개선이도소저항등도경증강란소공능,제공생육능력.근년래감비약물인기구유감지、개선이도소저항등작용,피용우차류환자적치료,본문칙대근년래다낭란소종합정여육령기비반부녀생육능력급상관약물치료진행종술.
The relationship between obesity and fertility in women of childbearing age is very close, especial-ly abdominal obesity. Females with obesity often show oligomenorrhea, increased androgen levels and ovulation obsta-cle. In addition, studies show that obese people are more likely to have polycystic ovary syndrome, hyperandrogen-emia and metabolic abnormalities, compared with normal people. Disorder in sex hormones levels may be one of the key factors causing obesity of different types. Studies have confirmed that reducing of weight can correct sex hormone disorder, reduce androgen levels, establish regular menstrual cycle and restore ovulation, and thus improve the fertility of obese females. Previous experience applied drugs such as metformin to strengthen the function of ovary and pro-mote fertility by improving insulin resistance. In recent years, anti-obesity drugs are used for the treatment because of its functions of reducing fat and improving insulin resistance. This paper reviews the recent progress in polycystic ova-ry syndrome, fertility of obese women in child-bearing age, and related drug therapies.